amrinone has been researched along with Hypocalcemia in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zucchi, R | 1 |
| Poddighe, R | 1 |
| Mariani, M | 1 |
| Ronca, G | 1 |
1 other study available for amrinone and Hypocalcemia
| Article | Year |
|---|---|
Effect of amrinone in the working rat heart: influence of ischaemic damage, adenosine and calcium.
Topics: Adenosine; Amrinone; Animals; Calcium; Cardiac Output; Coronary Disease; Heart; Heart Rate; Hypocalc | 1990 |